GO:0070062 | extracellular vesicular exosome | 2.40e-05 | 3.46e-01 | 2.395 | 7 | 104 | 2400 |
GO:0035267 | NuA4 histone acetyltransferase complex | 2.44e-05 | 3.52e-01 | 8.009 | 2 | 4 | 14 |
GO:0005654 | nucleoplasm | 1.09e-04 | 1.00e+00 | 3.059 | 5 | 76 | 1082 |
GO:0016071 | mRNA metabolic process | 1.93e-04 | 1.00e+00 | 4.600 | 3 | 31 | 223 |
GO:0016070 | RNA metabolic process | 2.61e-04 | 1.00e+00 | 4.453 | 3 | 32 | 247 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.25e-04 | 1.00e+00 | 6.172 | 2 | 17 | 50 |
GO:0000502 | proteasome complex | 4.38e-04 | 1.00e+00 | 5.958 | 2 | 17 | 58 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 5.33e-04 | 1.00e+00 | 5.816 | 2 | 19 | 64 |
GO:0005829 | cytosol | 5.44e-04 | 1.00e+00 | 2.116 | 6 | 132 | 2496 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.50e-04 | 1.00e+00 | 5.794 | 2 | 22 | 65 |
GO:0004151 | dihydroorotase activity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.38e-04 | 1.00e+00 | 5.687 | 2 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 6.75e-04 | 1.00e+00 | 5.646 | 2 | 20 | 72 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.13e-04 | 1.00e+00 | 5.607 | 2 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.32e-04 | 1.00e+00 | 5.587 | 2 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.12e-04 | 1.00e+00 | 5.512 | 2 | 23 | 79 |
GO:0016020 | membrane | 8.83e-04 | 1.00e+00 | 2.423 | 5 | 90 | 1681 |
GO:0016363 | nuclear matrix | 1.08e-03 | 1.00e+00 | 5.308 | 2 | 12 | 91 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.10e-03 | 1.00e+00 | 5.293 | 2 | 21 | 92 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 2 | 2 |
GO:0005055 | laminin receptor activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0030529 | ribonucleoprotein complex | 1.62e-03 | 1.00e+00 | 5.009 | 2 | 8 | 112 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 2 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0000209 | protein polyubiquitination | 1.74e-03 | 1.00e+00 | 4.958 | 2 | 20 | 116 |
GO:0044267 | cellular protein metabolic process | 1.75e-03 | 1.00e+00 | 3.512 | 3 | 29 | 474 |
GO:0006325 | chromatin organization | 1.80e-03 | 1.00e+00 | 4.933 | 2 | 5 | 118 |
GO:0005634 | nucleus | 1.82e-03 | 1.00e+00 | 1.469 | 7 | 136 | 4559 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0006543 | glutamine catabolic process | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0016032 | viral process | 2.46e-03 | 1.00e+00 | 3.340 | 3 | 55 | 534 |
GO:0044281 | small molecule metabolic process | 2.63e-03 | 1.00e+00 | 2.574 | 4 | 58 | 1211 |
GO:0051414 | response to cortisol | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.85e-03 | 1.00e+00 | 4.597 | 2 | 32 | 149 |
GO:0042981 | regulation of apoptotic process | 2.89e-03 | 1.00e+00 | 4.587 | 2 | 24 | 150 |
GO:0030957 | Tat protein binding | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 3 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.73e-03 | 1.00e+00 | 4.398 | 2 | 20 | 171 |
GO:0000028 | ribosomal small subunit assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 4 | 8 |
GO:0070688 | MLL5-L complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0000812 | Swr1 complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 3 | 8 |
GO:0010467 | gene expression | 4.67e-03 | 1.00e+00 | 3.015 | 3 | 59 | 669 |
GO:0006228 | UTP biosynthetic process | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0014075 | response to amine | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0031000 | response to caffeine | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 9 |
GO:0006098 | pentose-phosphate shunt | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 4 | 10 |
GO:0019789 | SUMO ligase activity | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0043968 | histone H2A acetylation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 3 | 12 |
GO:0005838 | proteasome regulatory particle | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 7 | 12 |
GO:0031011 | Ino80 complex | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 3 | 14 |
GO:0050998 | nitric-oxide synthase binding | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0006541 | glutamine metabolic process | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0003678 | DNA helicase activity | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 3 | 17 |
GO:0022624 | proteasome accessory complex | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 8 | 17 |
GO:0017144 | drug metabolic process | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 18 |
GO:0005839 | proteasome core complex | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 8 | 18 |
GO:0048863 | stem cell differentiation | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 1 | 19 |
GO:0004298 | threonine-type endopeptidase activity | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 8 | 19 |
GO:0043234 | protein complex | 1.08e-02 | 1.00e+00 | 3.612 | 2 | 18 | 295 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 21 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0033574 | response to testosterone | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0030863 | cortical cytoskeleton | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 4 | 23 |
GO:0043236 | laminin binding | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 25 |
GO:0016925 | protein sumoylation | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 25 |
GO:0043022 | ribosome binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 27 |
GO:0050661 | NADP binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0071339 | MLL1 complex | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 27 |
GO:0043967 | histone H4 acetylation | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 4 | 27 |
GO:0019894 | kinesin binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 28 |
GO:0000278 | mitotic cell cycle | 1.84e-02 | 1.00e+00 | 3.205 | 2 | 48 | 391 |
GO:0001895 | retina homeostasis | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 36 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 4 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 2 | 38 |
GO:0022627 | cytosolic small ribosomal subunit | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 4 | 39 |
GO:0007595 | lactation | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 2 | 39 |
GO:0043066 | negative regulation of apoptotic process | 2.15e-02 | 1.00e+00 | 3.088 | 2 | 31 | 424 |
GO:0043195 | terminal bouton | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 1 | 41 |
GO:0032508 | DNA duplex unwinding | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 3 | 41 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.42e-02 | 1.00e+00 | 5.357 | 1 | 3 | 44 |
GO:0021762 | substantia nigra development | 2.42e-02 | 1.00e+00 | 5.357 | 1 | 2 | 44 |
GO:0035690 | cellular response to drug | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 2 | 49 |
GO:0031100 | organ regeneration | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 4 | 50 |
GO:0040008 | regulation of growth | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 5 | 50 |
GO:0005524 | ATP binding | 2.88e-02 | 1.00e+00 | 2.059 | 3 | 60 | 1298 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 54 |
GO:0000932 | cytoplasmic mRNA processing body | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 3 | 54 |
GO:0042995 | cell projection | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 6 | 60 |
GO:0006915 | apoptotic process | 3.55e-02 | 1.00e+00 | 2.700 | 2 | 33 | 555 |
GO:0006310 | DNA recombination | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 65 |
GO:0034329 | cell junction assembly | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 1 | 68 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 2 | 70 |
GO:0006334 | nucleosome assembly | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 2 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 6 | 74 |
GO:0001889 | liver development | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 4 | 77 |
GO:0007565 | female pregnancy | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 1 | 78 |
GO:0019083 | viral transcription | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 10 | 81 |
GO:0006415 | translational termination | 4.73e-02 | 1.00e+00 | 4.373 | 1 | 10 | 87 |
GO:0016605 | PML body | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 3 | 88 |
GO:0006928 | cellular component movement | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 8 | 91 |
GO:0006414 | translational elongation | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 13 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 5.63e-02 | 1.00e+00 | 4.116 | 1 | 10 | 104 |
GO:0014069 | postsynaptic density | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 3 | 105 |
GO:0005815 | microtubule organizing center | 5.89e-02 | 1.00e+00 | 4.048 | 1 | 5 | 109 |
GO:0072562 | blood microparticle | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 3 | 111 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.15e-02 | 1.00e+00 | 3.983 | 1 | 11 | 114 |
GO:0005515 | protein binding | 6.16e-02 | 1.00e+00 | 0.845 | 6 | 184 | 6024 |
GO:0019058 | viral life cycle | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 13 | 115 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 5 | 126 |
GO:0009615 | response to virus | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 6.94e-02 | 1.00e+00 | 3.805 | 1 | 9 | 129 |
GO:0006413 | translational initiation | 7.04e-02 | 1.00e+00 | 3.783 | 1 | 17 | 131 |
GO:0003735 | structural constituent of ribosome | 7.35e-02 | 1.00e+00 | 3.718 | 1 | 10 | 137 |
GO:0007507 | heart development | 7.46e-02 | 1.00e+00 | 3.697 | 1 | 7 | 139 |
GO:0016887 | ATPase activity | 7.51e-02 | 1.00e+00 | 3.687 | 1 | 7 | 140 |
GO:0006457 | protein folding | 7.66e-02 | 1.00e+00 | 3.656 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 7.77e-02 | 1.00e+00 | 3.636 | 1 | 7 | 145 |
GO:0046777 | protein autophosphorylation | 8.44e-02 | 1.00e+00 | 3.512 | 1 | 7 | 158 |
GO:0043687 | post-translational protein modification | 8.64e-02 | 1.00e+00 | 3.476 | 1 | 5 | 162 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.80e-02 | 1.00e+00 | 3.450 | 1 | 7 | 165 |
GO:0030424 | axon | 8.85e-02 | 1.00e+00 | 3.441 | 1 | 4 | 166 |
GO:0004672 | protein kinase activity | 9.41e-02 | 1.00e+00 | 3.348 | 1 | 6 | 177 |
GO:0031625 | ubiquitin protein ligase binding | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 14 | 178 |
GO:0044822 | poly(A) RNA binding | 1.12e-01 | 1.00e+00 | 1.772 | 2 | 49 | 1056 |
GO:0007067 | mitotic nuclear division | 1.19e-01 | 1.00e+00 | 2.990 | 1 | 14 | 227 |
GO:0006412 | translation | 1.21e-01 | 1.00e+00 | 2.971 | 1 | 20 | 230 |
GO:0043025 | neuronal cell body | 1.28e-01 | 1.00e+00 | 2.879 | 1 | 9 | 245 |
GO:0005975 | carbohydrate metabolic process | 1.32e-01 | 1.00e+00 | 2.833 | 1 | 9 | 253 |
GO:0007283 | spermatogenesis | 1.36e-01 | 1.00e+00 | 2.783 | 1 | 8 | 262 |
GO:0006281 | DNA repair | 1.36e-01 | 1.00e+00 | 2.788 | 1 | 18 | 261 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 8 | 264 |
GO:0019899 | enzyme binding | 1.44e-01 | 1.00e+00 | 2.702 | 1 | 12 | 277 |
GO:0005856 | cytoskeleton | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 12 | 291 |
GO:0019901 | protein kinase binding | 1.63e-01 | 1.00e+00 | 2.508 | 1 | 21 | 317 |
GO:0043231 | intracellular membrane-bounded organelle | 1.63e-01 | 1.00e+00 | 2.503 | 1 | 9 | 318 |
GO:0007411 | axon guidance | 1.64e-01 | 1.00e+00 | 2.499 | 1 | 13 | 319 |
GO:0005925 | focal adhesion | 1.86e-01 | 1.00e+00 | 2.300 | 1 | 19 | 366 |
GO:0007155 | cell adhesion | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 6 | 369 |
GO:0055114 | oxidation-reduction process | 2.11e-01 | 1.00e+00 | 2.102 | 1 | 12 | 420 |
GO:0007596 | blood coagulation | 2.26e-01 | 1.00e+00 | 1.986 | 1 | 18 | 455 |
GO:0042802 | identical protein binding | 2.39e-01 | 1.00e+00 | 1.897 | 1 | 20 | 484 |
GO:0045087 | innate immune response | 2.87e-01 | 1.00e+00 | 1.597 | 1 | 24 | 596 |
GO:0005794 | Golgi apparatus | 2.92e-01 | 1.00e+00 | 1.563 | 1 | 15 | 610 |
GO:0005737 | cytoplasm | 3.49e-01 | 1.00e+00 | 0.522 | 3 | 110 | 3767 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.62e-01 | 1.00e+00 | 1.192 | 1 | 19 | 789 |
GO:0005615 | extracellular space | 4.23e-01 | 1.00e+00 | 0.914 | 1 | 17 | 957 |
GO:0008270 | zinc ion binding | 4.36e-01 | 1.00e+00 | 0.855 | 1 | 12 | 997 |
GO:0006351 | transcription, DNA-templated | 5.71e-01 | 1.00e+00 | 0.318 | 1 | 31 | 1446 |
GO:0005730 | nucleolus | 6.20e-01 | 1.00e+00 | 0.136 | 1 | 69 | 1641 |
GO:0005886 | plasma membrane | 7.94e-01 | 1.00e+00 | -0.518 | 1 | 45 | 2582 |